Plasminogen activator inhibitor type-1-deficient mice have an enhanced IFN-γ response to lipopolysaccharide and staphylococcal enterotoxin B

Journal of Immunology

Volumn 177, Issue 11, 2006, Pages 8171-8176

  Renckens, Rosemarijn ^a,b   Pater, Jennie M ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; STAPHYLOCOCCUS ENTEROTOXIN B; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FIBRINOLYSIS; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SEPSIS; SPLEEN CELL; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33751557764     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.11.8171     Document Type: Article

References (26)

1. Mondino, A., and F. Blasi. 2004. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 25: 450-455.
2. Lijnen, H. R. 2005. Pleiotropic functions of plasminogen activator inhibitor-1. J. Thromb. Haemost. 3: 35-45.
3. Pralong, G., T. Calandra, M. P. Glauser, J. Schellekens, J. Verhoef, F. Bachmann, and E. K. Kruithof. 1989. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb. Haemost. 61: 459-462.
4. Lorente, J. A., L. J. Garcia-Frade, L. Landin, R. de Pablo, C. Torrado, E. Renes, and A. Garcia-Avello. 1993. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103: 1536-1542.
5. Westendorp, R, G., J. J. Hottenga, and P. E. Slagboom. 1999. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 354: 561-563.
6. Hermans, P. W., M. L. Hibberd, R. Booy, O. Daramola, J. A. Hazelzet, R. de Groot, and M. Levin. 1999. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease: Meningococcal Research Group. Lancet 354: 556-560.
7. Burysek, L., T. Syrovets, and T. Simmet. 2002. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and Janus kinase (JAK)/STAT signaling pathways. J. Biol. Chem. 277: 33509-33517.
8. Syrovets, T., A. Schule, M. Jendrach, B. Buchele, and T. Simmet. 2002. Ciglitazone inhibits plasmin-induced proinflammatory monocyte activation via modulation of p38 MAP kinase activity. Thromb. Haemost. 88: 274-281.
9. Branger, J., B. van den Blink, S. Weijer, J. Madwed, C. L. Bos, A. Gupta, C. L. Yong, S. H. Polmar, D. P. Olszyna, C. E. Hack, et al. 2002. Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J. Immunol. 168: 4070-4077.
10. Branger, J., B. van den Blink, S. Weijer, A. Gupta, S. J. van Deventer, C. E. Hack, M. P. Peppelenbosch, and T. van der Poll. 2003. Inhibition of coagulation, fibrinolysis and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. Blood 101: 4446-4448.
11. Syrovets, T., M. Jendrach, A. Rohwedder, A. Schule, and T. Simmet. 2001. Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKβ-mediated NF-κB activation. Blood 97: 3941-3950.
12. Weide, I., J. Romisch, and T. Simmet. 1994. Contact activation triggers stimulation of the monocyte 5-lipoxygenase pathway via plasmin. Blood 83: 1941-1951.
13. Chang, W. C., G. Y. Shi, Y. H. Chow, L. C. Chang, J. S. Hau, M. T. Lin, C. J. Jen, L. Y. Wing, and H. L. Wu. 1993. Human plasmin induces a receptor-mediated arachidonate release coupled with G proteins in endothelial cells. Am. J. Physiol. 264: C271-C281.
14. Abraham, E., M. R. Gyetko, K. Kuhn, J. Arcaroli, D. Strassheim, J. Park, S. Shetty, and S. Idell. 2003. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J. Immunol. 170: 5644-5651.
15. Gyetko, M. R., G. H. Chen, R. A. McDonald, R. Goodman, G. B. Huffnagle, C. C. Wilkinson, J. A. Fuller, and G. B. Toews. 1996. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. J. Clin. Invest. 97: 1818-1826.
16. Gyetko, M. R., S. Sud, T. Kendall, J. A. Fuller, M. W. Newstead, and T. J. Standiford. 2000. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J. Immunol. 165: 1513-1519.
17. Miethke, T., C. Wahl, D. Regele, H. Gaus, K. Heeg, and H. Wagner. 1993. Superantigen mediated shock: a cytokine release syndrome. Immunobiology 189: 270-284.
18. Dinges, M., P. Orwin, and P. Schlievert. 2000. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 13: 16-34.
19. Lauw, F. N., S. Florquin, P. Speelman, S. J. van Deventer, and T. van der Poll. 2001. Role of endogenous interleukin-12 in immune response to staphylococcal enterotoxin B in mice. Infect. Immun. 69: 5949-5952.
20. Beutler, B., and E. Rietschel. 2003. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3: 169-176.
21. Renckens, R., S. Weijer, A. F. de Vos, J. M. Pater, J. C. Meijers, C. E. Hack, M. Levi, and T. van der Poll. 2004. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia. Arterioscler. Thromb. Vasc. Biol. 24: 483-488.
22. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
23. Sejima, T., S. Madoiwa, J. Mimuro, T. Sugo, K. Okada, S. Ueshima, O. Matsuo, T. Ishida, K. Ichimura, and Y. Sakata. 2005. Protection of plasminogen activator inhibitor-1-deficient mice from nasal allergy. J. Immunol. 174: 8135-8143.
24. Heinzel, F. P. 1990. The role of IFN-γ in the pathology of experimental endotoxemia. J. Immunol. 145: 2920-2924.
25. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh, and J. A. Norton. 1992. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J. Immunol. 149: 1666-1670.
26. Car, B. D., V. M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumann, M. Aguet, and B. Ryffel. 1994. Interferon γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179: 1437-1444.